| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.062 | 0.2 |